24/09/2025
A Challenging Case of STEC-HUS with Secondary Sepsis 🌟
Case summary:
73-year-old female admitted elsewhere with acute gastroenteritis, started on IV fluids and antibiotics. She deteriorated with shock, AKI requiring dialysis by day 3. Stool PCR confirmed STEC.
When shifted to our ICU:
Antibiotics stopped (no role in STEC initially).
Sepsis panel sent (negative).
Managed with fluids, dialysis started for worsening renal parameters.
Diagnosis: STEC-HUS (MAHA, AKI, but intact sensorium initially).
Neurological course:
On day 2 of dialysis, sensorium worsened, nystagmus noted.
EEG: metabolic encephalopathy.
CT brain: normal.
Progressed to GCS 3 → intubated.
Day 4: worsening TLC, shock, seizures (one GTCS), MRI: post-ictal changes.
Diagnostic dilemma:
Overlap STEC-HUS vs atypical HUS vs TTP considered.
Complements were high → atypical HUS less likely.
Planned plasma exchange but wanted to exclude secondary sepsis before proceeding.
Breakthrough:
Repeat sepsis panel + CSF: Stenotrophomonas maltophilia.
Treatment: Bactrim + Minocycline.
Course in ICU:
Continued dialysis (4 sessions total).
Shock resolved.
Sensorium improved.
No further seizures on AEDs.
Renal function recovered, dialysis stopped.
TLC & LFTs improved.
Extubated on day 8.
🔑 Clinical Pearls:
STEC-HUS: Antibiotics are usually avoided as they can worsen toxin release.
Atypical HUS: Consider if complements low/normal; in this case, complements were high, helping rule out.
TTP overlap: Always think of it when there’s MAHA + neurological worsening. Plasma exchange may be lifesaving—but rule out infection first.
Stenotrophomonas maltophilia: An opportunistic pathogen in critically ill/dialysis patients—early recognition and targeted therapy (Bactrim ± Minocycline) can be lifesaving.
EEG/MRI + CSF workup: Helped avoid unnecessary plasma exchange and directed therapy.
Multidisciplinary approach: Sequential thinking (HUS → atypical HUS → TTP → secondary sepsis) was key to survival in this complex case.
âś… Outcome: Patient improved, extubated, and recovering.
This case highlights the fine balance between timely immunomodulation and infection control in critically ill HUS patients.